Highlights Olink Holding AB

Equities

OLK

US6807101000

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-03 pm EDT			5-day change	1st Jan Change
23.01 ^USD	-0.04%		-0.26%	-8.51%

Apr. 11	Metacon Appoints New Finance Chief	MT
Mar. 25	Olink Swings to Q4 Net Loss, Revenue Rises	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Olink Swings to Q4 Net Loss, Revenue Rises	Mar. 25	MT
Olink Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
Olink Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 25	CI
Thermo Fisher Scientific Extends Tender Offer Expiration for Olink Holding Shares	Mar. 01	MT
Global markets live: Meta, Amazon, Apple, Tesla, Intel...	Feb. 02
UK Competition Watchdog to Probe Thermo Fisher Scientific's Potential Acquisition of Olink	Feb. 02	MT
Thermo Fisher Scientific Extends Expiration of Tender Offer for Olink Shares, ADSs	Dec. 15	MT
Thermo Fisher Scientific Unit Extends Expiration of Tender Offer for Olink Shares, ADS	Dec. 01	MT
Olink Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 15	CI
Thermo Fisher Scientific to Buy Proteomics Solutions Provider Olink in $3.1 Billion Deal	23-10-17	MT
Olink Holding Shares Soar on Takeover by Thermo Fisher	23-10-17	DJ
Thermo Fisher Scientific to Acquire Olink for $26 per Share in Cash	23-10-17	MT
Thermo Fisher Scientific to buy Olink in $3.1 billion deal	23-10-17	RE
Thermo Fisher to Buy Olink in $3.1 Billion Deal	23-10-17	DJ
Thermo Fisher Scientific to Acquire Olink for $26 per Share	23-10-17	MT
Thermo Fisher Scientific Agrees to Acquire Olink for $26 per Share	23-10-17	MT
Thermo Fisher Scientific Inc. proposed an offer to acquire Olink Holding AB for approximately $3.3 billion.	23-10-16	CI
Olink Holding AB Demonstrates the Power of the Olink Explore Platform for Driving Impactful Proteogenomic Studies At the Population Scale	23-10-05	CI
Olink Holding AB Announces the Introduction of Olink(R) Target 48 Mouse Cytokine Panel	23-09-19	CI
Eurofins Genomics Adopts Olink® Technology to Advance Proteomics Research and Accelerate Precision Medicine Programs	23-09-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Olink Holding AB

Equities

OLK

US6807101000

Highlights

Filters